IV immunoglobulin therapy enhances QOL in stiff-person syndrome

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.371, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IV immunoglobulin G successfully treated a paediatric patient with stiff-person syndrome

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Interferon-α: Stiff person syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Patients with common variable immunodeficiency (CVID) requiring IV immunoglobulin (IVIG) therapy have poorer health-related (HR) QOL than individuals with other chronic diseases

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Lamotrigine: Drug hypersensitivity syndrome treated with IV immunoglobulin: case report

Reactions Weekly, Vol. 1, Iss. 1411, 2012-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

IV immunoglobulin (IVIG) is a valid maintenance therapy option for myasthenia gravis

Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite